Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on: July 05,2024

Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on:July 05,2024

Researchers find protein that mediates formation of HER2-driven breast cancer

by Katie Pence,University of Cincinnati Academic Health CenterCredit: CC0 Public DomainResearchers at the University of Cincinnati College of Medicine have identified for the first time that the

Updated on: June 22,2024

Researchers find protein that mediates formation of HER2-driven breast cancer

by Katie Pence,University of Cincinnati Academic Health CenterCredit: CC0 Public DomainResearchers at the University of Cincinnati College of Medicine have identified for the first time that the

Updated on:June 22,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on: March 01,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on:March 01,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on: April 07,2024

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with

Updated on:April 07,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Updated on: January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Updated on:January 22,2024

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Updated on: June 28,2024

Aggressive breast cancers store large amounts of energy, which enables it to spread: study

by University of MichiganSofia Merajver, M.D., Ph.D. Credit: University of Michigan Rogel Cancer CenterCancer cells—especially the more aggressive ones—seem to have an ability to change. It's

Updated on:June 28,2024

Researchers identify the mutations that drive resistance to PI3K inhibitors in breast cancer, find they can be overcome

by Mass General BrighamSecondary mutations in the PI3K/AKT pathway emerge during treatment with inavolisib and lead to acquired resistance. A-B, Droplet digital PCR analysis of serial ctDNA sampl

Updated on: June 24,2024

Researchers identify the mutations that drive resistance to PI3K inhibitors in breast cancer, find they can be overcome

by Mass General BrighamSecondary mutations in the PI3K/AKT pathway emerge during treatment with inavolisib and lead to acquired resistance. A-B, Droplet digital PCR analysis of serial ctDNA sampl

Updated on:June 24,2024

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on: September 10,2024

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Updated on:September 10,2024

Neutrons reveal how a common tropical plant preys on cancer, preserves healthy cells

by Oak Ridge National LaboratoryFrom left are UWindsor students Isabelle Dib, Dominik Dziura, Stuart Castillo and Maksymilian Dziura at ORNL’s Neutron Spin Echo spectrometer. Their work advances

Updated on: February 23,2024

Neutrons reveal how a common tropical plant preys on cancer, preserves healthy cells

by Oak Ridge National LaboratoryFrom left are UWindsor students Isabelle Dib, Dominik Dziura, Stuart Castillo and Maksymilian Dziura at ORNL’s Neutron Spin Echo spectrometer. Their work advances

Updated on:February 23,2024

Researchers identify subtypes of squamous cell lung cancer

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainLung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer

Updated on: June 06,2024

Researchers identify subtypes of squamous cell lung cancer

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainLung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer

Updated on:June 06,2024

Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on: November 08,2024

Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on:November 08,2024

Study offers guidance for improving access to oncology drug treatments in sub-Saharan Africa

byRutgers UniversityCredit: CC0 Public DomainWith cancer rates rising throughout sub-Saharan Africa—home to 1.1 billion people, or about 14% of the world's population—researchers with the Bo

Updated on: January 30,2024

Study offers guidance for improving access to oncology drug treatments in sub-Saharan Africa

byRutgers UniversityCredit: CC0 Public DomainWith cancer rates rising throughout sub-Saharan Africa—home to 1.1 billion people, or about 14% of the world's population—researchers with the Bo

Updated on:January 30,2024